期刊文献+

氨甲环酸对减少同期双侧全髋关节置换术围术期出血的疗效 被引量:11

Combination of intravenous and local application of tranexamic acid significantly reduce blood loss in simultaneous bilateral total hip arthroplasty
下载PDF
导出
摘要 目的探讨静脉结合关节内注射氨甲环酸对于减少同期双侧人工全髋关节置换术后出血的有效性和安全性。方法回顾分析2013-10至2015-08同期行双侧人工全髋关节置换术患者病历资料,实验组在术前静脉给予氨甲环酸1 g,单侧手术结束后分别在关节腔内局部给3 g氨甲环酸,共计24例;选取术中及术后均未使用氨甲环酸的患者病历资料为对照组,共计24例,与实验组对照分析。分析术后引流量、血常规、有无输血、输血量,以及有无症状性静脉栓塞。结果氨甲环酸实验组术后总引流量(355.4 ml)、总失血量(1894.1 ml),隐性失血量(1538.7 ml)、总输血量360 ml、输血率(50%)均显著低于对照组(P<0.05)。实验组在术中失血量(954.2 ml)、出院前血红蛋白水平(95 g/L)、出院前血小板计数(157.8×109/L)与对照组比较差异无统计学意义。两组均未发生症状性静脉血栓和肺栓塞。结论同期双侧人工全髋关节置换术结合静脉及局部使用氨甲环酸可有效减少出血量,且不增加血栓栓塞的风险。 Objective To study the efficacy and safety of tranexamic acid for simultaneous bilateral total hip arthroplasty.Methods From 2013 October to 2015 August,forty-eight simultaneous bilateral total hip arthroplasty( THA) were retrospectively analyzed. Combination of systemic and local application of tranexamic acid were given in twenty-four cases. No tranexamic acid was used in twenty-four cases as control group. Drain volume,total blood loss,hidden blood loss,transfusion rate and transfusion volume,hemoglobin level,platelet count,and symptomatic venous thromboembolism were recorded and compared. Results Drain volume,total blood loss,hidden blood loss,transfusion rate,transfusion volume in tranexamic acid group and control group were 355. 4 ml and574. 4 ml,1894. 1 ml and 2959. 3 ml,1538. 7 ml and 2384. 9 ml,50. 0% and 100. 0%,360 ml and 1340 ml,respectively,with significant difference( P 〈0. 05). There was no difference in intraoperative blood loss. No symptomatic venous thrombombolism was identified in either group. Conclusions Combination of systemic and local application of tranexamic acid significantly reduces blood loss for bilateral simultaneous total hip arthroplasty while does not increase the risk of venous thromboembolism.
出处 《武警医学》 CAS 2016年第2期119-122,共4页 Medical Journal of the Chinese People's Armed Police Force
关键词 氨甲环酸 人工全髋关节置换术 股骨头坏死 隐性出血 下肢深静脉血栓 tranexamic acid total hip arthroplasty avascular necrosis of femoral head hidden blood loss deep vein thrombosis
  • 相关文献

参考文献20

  • 1Vamvakas E C, Blajchman M A. Transfusion-related mor- tality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention [ J ]. Blood, 2009, 113(15) :3406-3417.
  • 2中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2009,29(6):602-604. 被引量:530
  • 3Nadler S B, Hidalgo J H, Bloch T. Prediction of blod volume in normal human adults[J]. Surgery, 1962, 51 (2) :224-232.
  • 4Gross J B. Estimating allowable blood loss: corrected for dilution [ J ]. Anesthesilogy, 1983, 58 ( 3 ) : 277-280.
  • 5Claeys M A, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip re- placement surgery[J]. Acta Chir Belg, 2007,107(4) : 397 -401.
  • 6Ekback G, Axelsson K, Ryttberg L, et al. Tranexamic acid reduces blood loss in total hip replacement surgery [ J ]. Anesth Analg ,2000, 91 ( 5 ) : 1124-1130.
  • 7Garneti N, Field J. Bone bleeding during total hip ar- throplasty after administration of tranexamic acid [ J ]. J Arthroplasty,2004, 19(4) :488-492.
  • 8Johansson T, Pettersson L G, Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients [ J ]. Ac- ta Orthop,2005, 76 (3) :314-319.
  • 9Lemay E, Guay J, Cote C, et al. Tranexamic acid re- duces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement [ J ]. Can J Anaesth,2004, 51 ( 1 ) :31-37.
  • 10Rajesparan K, Biant L C, Ahmad M, et al. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement[ Jl. J Bone Joint Surg Br,2009, 91 (6) :776-783.

二级参考文献19

  • 1邱贵兴,杨庆铭,余楠生,翁习生,王凯,李晓林.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12):819-822. 被引量:428
  • 2Ollendorf DA,Vera-Llonch M,Oster G.Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients.Am J Health Syst Pharm,2002,59(18):1750-1754.
  • 3Geerts WH,Pineo OF,Heir JA,et al.Prevention of venous thromboembolism:the Seventh ACCP Conference on Antithromboric and Thrombolytic Therapy.Chest,2004,126 (3 Suppl):S338-400.
  • 4Mosby's Dictionary of Medicine,Nursing & Health Professions.7th ed.St.Louis,MO:Mosby,2006:115-116,335,520,1454,1849,1949.
  • 5Piovella F,Wang CJ,Lu H,et al.Deep-vein thrombosis rates after major Orthopedic surgery in Asia:an epidemiological study based on postoperative screening with centrally adjudicated bilateral venography.J Thromb Haemost,2005,3(12):2664-2670.
  • 6Heir JA,O'Fallon WM,Petterson TM,et al.Relative impact of risk factors for deep vein thrombosis and pulmonary embolism:a population-based study.Arch Intern Med,2002,162 (11):1245-1248.
  • 7Anderson FA Jr,Spencer FA.Risk factors for venous thrombcembolism.Circulation,2003,107(23 Suppl 1):9-16.
  • 8Caprini JA.Thrombosis risk assessment as a guide to quality patient care.Dis Mon,2005,51(2/3):70-78.
  • 9Geerts WH,Heit JA,Clagett GP,et al.Prevention of venous thromboembolism.Chest,2001,119(1 Suppl):S132-175.
  • 10Snow V,Qaseem A,Barry P,et al.Management of venous thromboembolism:a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.Ann Intern Med,2007,146(3):204-210.

共引文献529

同被引文献85

引证文献11

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部